Tam L&M Digital therapeutics (DTx) brand Fitterfly released its year-end report called Reimagining Diabetes Care Report 2022 for the period January-December 2022. Based on a sample size of over 3,000 people who enrolled into Fitterfly’s Diabetes Management programs, the report underscores the need to reimagine, rethink, and reassess diabetes before it reaches pandemic proportions. It […]Read More
